IRIS - Res&Arch Institutional Research Information System - Research & Archive

LAZZERI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.716
EU - Europa 3.397
AS - Asia 2.409
SA - Sud America 447
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 10.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.604
SG - Singapore 961
IT - Italia 841
UA - Ucraina 646
IE - Irlanda 505
HK - Hong Kong 465
SE - Svezia 455
BR - Brasile 388
VN - Vietnam 323
CN - Cina 321
RU - Federazione Russa 303
DE - Germania 185
KR - Corea 162
FI - Finlandia 157
CA - Canada 72
GB - Regno Unito 71
TR - Turchia 45
FR - Francia 36
BE - Belgio 34
CH - Svizzera 33
PL - Polonia 30
AT - Austria 27
NL - Olanda 25
AR - Argentina 24
MX - Messico 21
BD - Bangladesh 20
IN - India 19
ES - Italia 15
UZ - Uzbekistan 15
JP - Giappone 12
PK - Pakistan 10
LB - Libano 9
ZA - Sudafrica 9
CL - Cile 8
CO - Colombia 7
CZ - Repubblica Ceca 7
EU - Europa 7
ID - Indonesia 7
IQ - Iraq 7
IR - Iran 6
PY - Paraguay 6
EC - Ecuador 5
MA - Marocco 5
AU - Australia 4
EG - Egitto 4
GR - Grecia 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
GT - Guatemala 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BH - Bahrain 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
HT - Haiti 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.011
Salva come PNG Salva come JPEG
Città #
Singapore 625
Chandler 621
Dublin 505
Hong Kong 459
Jacksonville 319
San Mateo 311
Dong Ket 237
Boardman 188
Ashburn 163
Seoul 162
Santa Clara 147
Medford 128
Princeton 128
Wilmington 103
Altamura 92
Perugia 81
Beijing 77
Moscow 75
Lawrence 73
Des Moines 72
Andover 68
Ann Arbor 68
Ottawa 50
Piscataway 45
Saint Petersburg 43
Shanghai 41
Rome 40
Los Angeles 38
São Paulo 36
Munich 35
Brussels 34
Milan 33
Ho Chi Minh City 32
New York 31
Izmir 26
Norwalk 25
Vienna 18
Falls Church 17
Warsaw 17
Hanoi 16
Helsinki 16
San Paolo di Civitate 16
Woodbridge 16
Redwood City 13
Florence 12
Tokyo 12
Turku 12
Brooklyn 11
San Francisco 11
Atlanta 10
Council Bluffs 10
Houston 10
Rio de Janeiro 10
Bologna 9
Istanbul 9
Montreal 9
Naples 9
Ribeirão Preto 9
Charlotte 8
Dallas 8
Tashkent 8
Terni 8
Belo Horizonte 7
Den Haag 7
Dhaka 7
Stockholm 7
West Jordan 7
Cagliari 6
Chicago 6
Columbus 6
Frankfurt am Main 6
Manchester 6
Orem 6
Padova 6
Redmond 6
Campinas 5
Castrovillari 5
Changsha 5
Hefei 5
Johannesburg 5
Marília 5
Napoli 5
Philadelphia 5
Phoenix 5
San Jose 5
Toronto 5
Turin 5
Auburn Hills 4
Biên Hòa 4
Boston 4
Brasília 4
Camisano Vicentino 4
Chennai 4
Genova 4
Islamabad 4
Jakarta 4
Jinan 4
Juiz de Fora 4
Palermo 4
Poplar 4
Totale 5.710
Salva come PNG Salva come JPEG
Nome #
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 350
Ruolo della colposospensione sec.Burch associata a ricostruzione integrale per via addominale in pazienti continenti e incontinenti affette da prolasso urogenitale avanzato. Rivalutazione a lungo termine di 2 studi clinici randomizzati 350
ABDOMINAL VS LAPAROSCOPIC SACROPEXY: SUBGROUP ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL 248
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 244
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 222
Valutazione dell’attività sessuale mediante questionario FSFI in pazienti sottoposte a sling medio-uretrale: studio multicentrico 162
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 141
Performance of incontinence impact questionnaire (IIQ) in italian population according to educational status 129
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair? A case control study 120
Abdominal pelvic floor reconstruction with uterus preservation 115
Evaluation of Prostate-Specific Antigen Isoform p2PSA and Its Derivates, %p2PSA, Prostate Health Index and Prostate Dimension-Adjusted Related Index in the Detection of Prostate Cancer at First Biopsy: An Exploratory, Prospective Study. 115
Master di II livello in uroginecologia: quali i risultati chirurgici 113
Valutazione dell’attività sessuale pre e post operatoria mediante questionario FSFI in pazienti sottoposti a sling medio uretrale 113
Long-term outcome of anti-incontinence procedure during Pelvic Organ Prolapse repair in patients with or without urinary incontinence: results from two randomized surgical trials 113
Uterovaginal prolapse in a woman desiring uterus preservation. Case Presentation with Expert discussion 112
Abdominal integral pelvic reconstruction plus or minus Burch colposuspension in the treatment of severe uro-genital prolapse associated to urinary incontinence. A RCT with a mid-term follow up 110
Abdominal vs laparoscopic sacrocolpopexy: subgroup analysis of a prospective randomized trial 104
Management of healing abnormalities after abdominal pelvic organ prolapse repair 101
Prulifloxacin vs Phosphomycin: Prophylaxis in patients with recurrent UTI. Preliminary results of a randomized multi-centre study 99
Il ruolo del MUCP e del VLPP preoperatori nel predirre i risultati delle pazienti sottoposte a TOT 98
Long-Term follow-up uterus sparing surgery for pelvic organ prolapse (POP) 98
Retropubic versus transobturator mid-urethral slings: in a randomised controlled trial pre-operative VLPP may not predict mid-term outcome 96
Editorial comment on: Cizolirtine Citrate is safe and effective for treating Urinary Incontinence secondary to overactive bladder: a Phase 2 proof-of-concept study 94
The management of healing abnormalities after abdominal pelvic organ prolapse repair 91
POLYVINYLIDENFLUORID (PVDF) AND POLYPROPYLENE MESH FOR SACROCOLPOPEXY: A COMPARATIVE STUDY 91
Surgical outcome during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair: case control study 90
Urinary Tract Infections in Women With Type 1 Diabetes Mellitus: Survey of Female Participants in the Epidemiology of Diabetes Interventions and Complications Study Cohort COMMENT 90
Profilassi con Plurifloxacina vs Fosfomicina in pawienti affette da cistiti ricorrenti. Risultati preliminari di uno studio randomizzato 90
Overactive bladder symptoms (OAB) and detrusor overactivity (DO) in patients with posterior vault prolapse: Prevalence and its changes after POP repair 90
Uterus sparing surgery: A paradigm shift. Effectively managing POP includes prioritising patient’s wish 89
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 89
Uro-genital prolapse surgery: update on post-operative urinary incontinence 87
Female sexual function evaluation in patients who underwent integral pelvic floor reconstructive surgery 85
Burch colposuspension does not provide any additional benefit to pelvic organ prolapse repair in patients with urinary incontinence: A randomized surgical trial 84
Chirurgia del prolasso con preservazione dell’utero: risultati a lungo termine 82
Risultati chirurgici nelle donne in età avanzata 81
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent POP (Pelvic Organ Prolapse) repair 81
Preoperative urinary incontinence is the main risk factor for post operative incontinence in women who underwent pelvic organ prolapse repair 81
Changes in female sexual function after pelvic organ prolapse repair: role of hysterectomy 79
Open-Label, Longitudinal Study of Tamsulosin for Functional Bladder Outlet Obstruction in Women 78
IMPACT OF MID URETHRAL SLING ON FEMALE SEXUAL FUNCTION. A PROSPECTIVE MULTICENTRE STUDY 78
Cambiamenti della funzione sessuale nelle pazienti con sling medio-uretrali per incontinenza urinaria da stress 78
Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent pelvic organ prolapse repair 77
Preoperative MUCP and VLPP failed to predict outcome in patients who underwent transobturator mid-urethral slings 76
Patients of surgical educational course may have a poorer outcome for pelvic organ prolapse repair and higher complication rate: a case-control study in urogynecology 76
Uterus preservation in pelvic organ prolapse surgery 75
Prevalence of sexual activity in waiting list women for pelvic organ prolapse and/or urinary incontinence surgery: a cross sectional survey 75
FSFI: modificazioni dell’attività sessuale pre e post-intervento nelle pazienti sottoposte a chirurgia ricostruttiva del pavimento pelvico 74
Sexual changes after pop repair. Is hysterectomy a key element? 74
Impact of a teaching program on outcome quality of white light transurethral resection for bladder tumor: A cohort study 74
Long-term outcome of anti-incontinence procedure during pelvic organ prolapse repair in patients with and without urinary incontinence: results from two randomised controlled trials 73
Prolasso di volta a prevalenza posteriore: relazione con i sintomi da vescica iperattiva e con l’iperattività detrusoriale prima e dopo intervento chirurgico 73
Treatment of severe uro-genital prolapse associated with urinary incontinence by means of abdominal integral pelvic floor reconstruction with or without Burch colposuspension. A RCT with a mid-term follow-up 73
Lean Mean Research: The 21st Century Challenge for Urology 72
Profilassi in pazienti affette da cistiti ricorrenti: risultati preliminari di uno studio randomizzato multicentrico; prulifloxacina vs fosfomicina 72
Laparoscopic Versus Abdominal Sacrocolpopexy: A Randomized, Controlled Trial 72
Preoperative MUCP and VLPP may not predict mid-term outcome in patients who underwent transobturator mid-urethral slings (TOT) 72
Sexual changes after POP repair. Is hysterectomy a key element? 71
Deterioration of continence after TOT when the follow-up is extended: results from a randomised controlled study 71
Managing complications after midurethral sling for stress urinary incontinence 70
Sexual activity before and after mid urethral sling. A prospective multicentre study 70
Managing Mesh Erosion after Abdominal Pelvic Organ Prolapse Repair: Ten Years Experience in a Single Center 70
Urodynamics for Pelvic Organ Prolapse Surgery: "Par for the Course" 70
The Incontinence Impact Questionnaire: Results in an Italian Female Population Stratified by Educational Status 69
Cost-utility rations (CURs) and different levels of effectiveness in urinary incontinence (UI) management 69
Are We in a Robotic Surgical Bubble Market? 69
Colposacropessia laparoscopica versus Colposacropessia addominale: subanalisi di uno studio randomizzato 69
Is the tension-free vaginal tape procedure for stress urinary incontinence safe and effective in the long term? 69
Uterus sparing surgery for pelvic organ prolapse (POP): long term results 68
Pre-operative VLPP may not predict the mid-term out come of mid-urethral slings. A retrospective analysis from a randomized controller trial of TVT versus TOT mid-urethral slings 68
Deterioration of continence after TOT when the follow-up is extended: Results from a randomised controlled study 68
Five-year outcome of uterus sparing surgery for pelvic organ prolapse repair: a single-center experience 67
Fattori di rischio per l’incontinenza urinaria post-operatoria in pazienti affette da prolasso severo e sottoposte a ricostruzione integrale del pavimento pelvico 67
Long-term Efficacy of the Transobturator and Retropubic Midurethral Slings for Stress Urinary Incontinence: Single-center Update from a Randomized Controlled Trial. 66
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (sui) and pelvic organ prolapse (pop) repair? A case control study 65
Burch colposuspension and pelvic organ prolapse repair in patients with and without urinary incontinence: results from two randomised surgical trials 65
Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study 65
Preoperative Valsava Leak Point Pressure May Not Predict Outcome of Mid-Urethral Slings. Analysis from a Randomized Controlled Trial of Retropubic versus Transobturator Mid-Urethral Slings 64
Il ruolo degli ultrasuoni nella definizione del deficit sfinterico uretrale 63
Editorial comment on: Tension free vaginale tape in the management of recurrent urodynamics stress incontinence after previous failed midurethral tape 63
Il trattamento delle complicanze dopo chirurgia addominale per il prolasso degli organi pelvici 62
Posterior vault prolapse and overactive bladder symptoms (OAB): changes after POP repair 62
Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium Hyaluronate-chondroitin sulphate (Ialuril®). 62
Hysterectomy and stress urinary incontinence. 61
Sexual activity before and after mid urethral sling. A prospective multicentre study 61
The Challenge of the Overactive Bladder: From Laboratory to New Drugs 61
Surgical outcomes in aging women 60
Hydronephrosis and Pelvic Organ Prolapse 59
Iatrogenic Trapped Penis in Adults: New, Simple 2-Stage Repair 59
Pelvic organ prolapse and lower urinary tract symptoms: experience from a high-volume uro-gynecologic center 59
Cost-Utility Ratios (CURS) and different levels of effectiveness in urinary incontinence (UI) management 59
Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial. 59
Pelvic Organ Prolapse Repair With and Without Prophylactic Concomitant Burch Colposuspension in Continent Women: A Randomized, Controlled Trial With 8-Year Followup 57
Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence 57
Long-term follow-up of uterus sparing surgery for pelvic organ prolapse (POP) 55
Preoperative MUCP and VLPP Did Not Predict Long-Term (4-Year) Outcome after Transobturator Mid-Urethral Sling 55
L’analisi costo-utilità nel trattamento dell’incontinenza urinaria femminile 55
TRP family proteins in the lower urinary tract: translating basic science into new clinical prospective 54
The role of ultrasound in the definition of female urethral sphincter deficiency: one tertiary centre experience 53
Surgery for Stress Urinary Incontinence: So Near and Yet So Far 53
Totale 8.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021752 0 0 0 0 0 74 92 4 153 38 108 283
2021/20221.159 21 278 25 76 47 12 12 290 11 28 150 209
2022/20231.949 181 334 36 139 135 229 5 121 673 7 61 28
2023/2024967 34 84 46 23 18 15 299 82 119 22 131 94
2024/20251.631 81 175 89 49 264 65 15 114 320 110 206 143
2025/20261.622 269 219 142 446 373 173 0 0 0 0 0 0
Totale 10.238